Exact Mass: 1064.6622

Exact Mass Matches: 1064.6622

Found 28 metabolites which its exact mass value is equals to given mass value 1064.6622, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Ganglioside GA2 (d18:1/16:0)

N-[(2S,3R,4E)-1-{[(2R,4R,5S,6R)-5-{[(2S,3R,4R,5R,6R)-5-{[(2S,3R,4R,5R,6R)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexadecanimidate

C54H100N2O18 (1064.6971)


Ganglioside GA2 (d18:1/16:0) is a glycosphingolipid (ceramide and oligosaccharide)or oligoglycosylceramide with one or more sialic acids (i.e. n-acetylneuraminic acid) linked on the sugar chain. It is a component the cell plasma membrane which modulates cell signal transduction events. Gangliosides have been found to be highly important in immunology. Ganglioside GA2 carries a net-negative charge at pH 7.0 and is acidic. Gangliosides can amount to 6\\% of the weight of lipids from brain, but they are found at low levels in all animal tissues. Gangliosides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Gangliosides are very similar to globosides except that they also contain N-acetyl neuraminic acid (NANA) in varying amounts. The specific names for the gangliosides provide information about their structure. The letter G refers to ganglioside, and the subscripts M, D, T and Q indicate that the molecule contains mono-, di-, tri and quatra-sialic acid. The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide. In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands for GalGlc-ceramide. Deficiencies in lysosomal enzymes that degrade the carbohydrate portions of various gangliosides are responsible for a number of lysosomal storage diseases such as Tay-Sachs disease, Sandhoff disease, and GM1 gangliosidosis. The carbohydrate portion of the ganglioside GM1 is the site of attachment of cholera toxin, the protein secreted by Vibrio cholerae.

   

3,3-Di-O-glucopyranoside-Bacterioruberin

3,3-Di-O-glucopyranoside-Bacterioruberin

C62H96O14 (1064.68)


   

GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)

GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)

C54H100N2O18 (1064.6971)


   

Ganglioside GA2 (d18:1/16:0)

Ganglioside GA2 (d18:1/16:0)

C54H100N2O18 (1064.6971)


   

asialo-GM2(d18:1/16:0)

GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)

C54H100N2O18 (1064.6971)


   

Lc3Cer(d18:1/16:0)

GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)

C54H100N2O18 (1064.6971)


   

Hex-HexNAc-Cer 34:1;O2

GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/16:0)

C54H100N2O18 (1064.6971)


   

Bacterioruberin diglucoside

(2S,2S)-2,2-Bis-(3-glucosyloxy-3-methylbutyl)-3,4,3,4-tetradehydro-1,2,1,2-tetrahydro-psi,psi-carotene-1,1-diol

C62H96O14 (1064.68)


   

2-O-palmitoyl-2-O-sulfo-3-O-[(2E,4S,6S,8S)-2,4,6,8-tetramethyltetracos-2-enoyl]-alpha,alpha-trehalose

2-O-palmitoyl-2-O-sulfo-3-O-[(2E,4S,6S,8S)-2,4,6,8-tetramethyltetracos-2-enoyl]-alpha,alpha-trehalose

C56H104O16S (1064.7045)


   

Lc3Cer(d18:1(4E)/16:0)

Lc3Cer(d18:1(4E)/16:0)

C54H100N2O18 (1064.6971)


   

[3-[[3-[[3-[(E)-docos-13-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (12Z,15Z,18Z)-tetracosa-12,15,18-trienoate

[3-[[3-[[3-[(E)-docos-13-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (12Z,15Z,18Z)-tetracosa-12,15,18-trienoate

C55H102O15P2 (1064.6694)


   

[3-[[3-[[3-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] tetracosanoate

[3-[[3-[[3-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] tetracosanoate

C55H102O15P2 (1064.6694)


   

[3-[[3-[[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (E)-tetracos-15-enoate

[3-[[3-[[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (E)-tetracos-15-enoate

C55H102O15P2 (1064.6694)


   

[3-[[3-[(3-docosanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (9Z,12Z,15Z,18Z)-tetracosa-9,12,15,18-tetraenoate

[3-[[3-[(3-docosanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (9Z,12Z,15Z,18Z)-tetracosa-9,12,15,18-tetraenoate

C55H102O15P2 (1064.6694)


   

[3-[[3-[[3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (15Z,18Z)-tetracosa-15,18-dienoate

[3-[[3-[[3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (15Z,18Z)-tetracosa-15,18-dienoate

C55H102O15P2 (1064.6694)


   

Adgga 22:6_16:4_18:5

Adgga 22:6_16:4_18:5

C65H92O12 (1064.6588)


   

Adgga 18:5_18:5_20:5

Adgga 18:5_18:5_20:5

C65H92O12 (1064.6588)


   

Adgga 16:4_18:5_22:6

Adgga 16:4_18:5_22:6

C65H92O12 (1064.6588)


   

Adgga 18:5_16:4_22:6

Adgga 18:5_16:4_22:6

C65H92O12 (1064.6588)


   

Adgga 20:5_18:5_18:5

Adgga 20:5_18:5_18:5

C65H92O12 (1064.6588)


   

MLCL(45:4)

MLCL(9:0_18:2_18:2)

C54H98O16P2 (1064.633)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

DGDG O-47:12

DGDG O-47:12

C62H96O14 (1064.68)


   
   
   
   

CerG2GNAc1(34:1)

CerG2GNAc1(d18:1_16:0)

C54H100N2O18 (1064.6971)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

(5r,8s,11r,12s,15s,18s,19s,22r)-15-(3-carbamimidamidopropyl)-3,6,9,13,16,20-hexahydroxy-18-[(1e,3e,5s,6s)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dien-1-yl]-22-(methoxycarbonyl)-1,12,19-trimethyl-8-[(2s)-2-methylbutyl]-2-methylidene-5-(2-methylpropyl)-25-oxo-1,4,7,10,14,17,21-heptaazacyclopentacosa-3,6,9,13,16,20-hexaene-11-carboxylic acid

(5r,8s,11r,12s,15s,18s,19s,22r)-15-(3-carbamimidamidopropyl)-3,6,9,13,16,20-hexahydroxy-18-[(1e,3e,5s,6s)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dien-1-yl]-22-(methoxycarbonyl)-1,12,19-trimethyl-8-[(2s)-2-methylbutyl]-2-methylidene-5-(2-methylpropyl)-25-oxo-1,4,7,10,14,17,21-heptaazacyclopentacosa-3,6,9,13,16,20-hexaene-11-carboxylic acid

C54H84N10O12 (1064.627)


   

3-[(2-{[(4z)-1,3-dihydroxydodec-4-en-1-ylidene]amino}-1-hydroxy-4-methylpentylidene)amino]-3-{[5,8,11,14,17-pentahydroxy-9-(hydroxymethyl)-19-methyl-6,12,15-tris(2-methylpropyl)-2-oxo-3-(sec-butyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-18-yl]-c-hydroxycarbonimidoyl}propanoic acid

3-[(2-{[(4z)-1,3-dihydroxydodec-4-en-1-ylidene]amino}-1-hydroxy-4-methylpentylidene)amino]-3-{[5,8,11,14,17-pentahydroxy-9-(hydroxymethyl)-19-methyl-6,12,15-tris(2-methylpropyl)-2-oxo-3-(sec-butyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-18-yl]-c-hydroxycarbonimidoyl}propanoic acid

C53H92N8O14 (1064.6733)